Home › Funds › Penn Capital Management Company, LLC › TGTX
Penn Capital Management Company, LLC position in TGTX
TG THERAPEUTICS INC · Health Care
Penn Capital Management Company, LLC reported holding 480,881 shares of TGTX (TG THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 1.99% of its reported portfolio and ranking #3 among its reported holdings. Penn Capital Management Company, LLC has disclosed TGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Penn Capital Management Company, LLC's TGTX position evolved
Penn Capital Management Company, LLC first disclosed a stake in TGTX in Q4 2024 at 351,408 shares (US$10.6M). The position peaked in Q2 2026 at 536,067 shares, worth US$29.5M. Across 8 filings, Penn Capital Management Company, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 480,881 shares valued at US$26.9M — a reduction of -55,186 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 351.41K | $10.58M | New |
| Q1 2025 | 392.18K | $15.51M | Add |
| Q2 2025 | 443.37K | $16.00M | Add |
| Q3 2025 | 521.26K | $18.88M | Add |
| Q4 2025 | 538.12K | $16.08M | Add |
| Q1 2026 | 541.96K | $18.05M | Add |
| Q2 2026 | 536.07K | $29.51M | Reduce |
| Q3 2026 | 480.88K | $26.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TGTX and 13F data
TGTX (TG THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TGTX
- Soleus Capital Management, L.P. 2.93M sh · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M sh · $145.39M · Q3 2026
- Opaleye Management Inc. 535.00K sh · $29.39M · Q2 2026
- Occam Crest Management LP 425.00K sh · $22.73M · Q2 2026
- 683 Capital Management, LLC 389.08K sh · $21.38M · Q2 2026
More on Penn Capital Management Company, LLC
FAQ
How long has Penn Capital Management Company, LLC held TGTX?
Penn Capital Management Company, LLC has disclosed TGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Penn Capital Management Company, LLC's current position in TGTX?
As of Q3 2026, Penn Capital Management Company, LLC holds 480.88K shares of TGTX (TG THERAPEUTICS INC), valued at $26.88M, representing 1.99% of its reported portfolio and ranking #3.
Has Penn Capital Management Company, LLC been buying or selling TGTX?
In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC reduced its position in TGTX. The position peaked in Q2 2026 at 536.07K shares.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.